DOJ Demonstrates Continued Focus on Opioid Crisis with $600 Million Criminal and Civil Settlement Against Indivior Solutions, Indivior Inc., and Indivior plc

The Dorsey Health Law blog team keeps readers up-to-date on relevant topics in the health care industry. In order to do so, the members of the blog team communicate regularly with other practice groups within the firm for applicable updates from client publications. We would like to thank Vanessa J. Szalapski for the following post from Dorsey’s FCA Now blog:

The Department of Justice’s (“DOJ”) most recent settlement with Indivior Solutions, Inc., Indivior Inc., and Indivior plc (together, “Indivior”) demonstrates not only that the DOJ is continuing its pursuit of claims and settlements related to the opioid crisis, but also that the DOJ is searching for creative penalties beyond large monetary payouts. [Continue Reading]

Vanessa J. Szalapski

Vanessa J. Szalapski

As an associate in the Trial Group, Vanessa serves clients in both federal and state court on a wide variety of matters, including class action, securities, consumer protection, health, Telephone Consumer Protection Act (TCPA), and trust litigation.

You may also like...